Pneumocystis Pneumonia: Clinical Trials

4 trials for Pneumocystis Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 not yet recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Unknown 2, Completed 1, Not yet recruiting 1

Follow Pneumocystis Pneumonia: new trials by email Literature Review of Pneumocystis Pneumonia trials Research Report on Pneumocystis Pneumonia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
How Long Should we Give Steroids for Patients With Severe PCP
Systemic corticosteroids - Pneumocystis Pneumonia, Pneumocystis
Phase 4Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre4162026-01-302026-01-09
Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP
caspofungin, TMP/SMZ(trimethoprim/sulfisoxazole), Methylprednisolone - Pneumocystis Pneumonia
Phase 4UnknownBin Du1222019-08-142019-09-12
Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria
Cotrimoxazole, Placebo - HIV-1-infection, Pneumocystis Pneumonia
Phase 4CompletedUniversity of Bergen5372017-03-302019-10-02
Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
Dapsone, HLA-B*1301 - Allergic Cutaneous Vasculitis, Urticaria
Phase 4UnknownShandong Provincial Institute of Dermatology and Venereology31302015-07-012017-03-03

Narrower conditions

Pneumonia, Pneumocystis (4)  ·  Acne Vulgaris (1)  ·  Infections (1)  ·  Leprosy (1)  ·  Opportunistic Infections (1)  ·  Pneumocystis Infections (1)  ·  Pneumonia (1)  ·  Psoriasis (1)  ·  Skin Diseases, Vesiculobullous (1)  ·  Urticaria (1)  ·  Vasculitis, Leukocytoclastic, Cutaneous (1)

Broader conditions

Bacterial Infections and Mycoses (4)  ·  Lung Diseases (4)  ·  Lung Diseases, Fungal (4)  ·  Mycoses (4)  ·  Respiratory Tract Diseases (4)  ·  Respiratory Tract Infections (4)  ·  Infections (3)  ·  Pneumocystis Infections (3)  ·  Pneumonia (3)  ·  Acneiform Eruptions (1)  ·  Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Cardiovascular Diseases (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Hypersensitivity (1)

Interventions

Caspofungin (1)  ·  Dapsone (1)  ·  Methylprednisolone (1)  ·  Sulfisoxazole (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)

Sponsors

Bin Du (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Shandong Provincial Institute of Dermatology and Venereology (1)  ·  University of Bergen (1)

Countries

China (2)  ·  Canada (1)  ·  Tanzania (1)

Top investigators

Furen Zhang (1)  ·  Joel Manyahi, MD (1)

Results publications

PMID 32653726, PMID 33586013, PMID 36803640